EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Fireside chat: advancing analytical science and regulatory readiness for nucleic acid medicines

Jonathan Neidigh, Michael Bartlett

Nucleic Acid Insights · 15.06.2026 · 3 (5) · 316–324

DOI: 10.18609/nuc.2026.037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acid Insights, online erschienen am 15.06.2026. Verfasst von Jonathan Neidigh und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

“LC-MS of oligonucleotides has advanced considerably and is approaching a level of maturity where more routine use outside R&D settings should be feasible.” Jonathan Neidigh (CMC Consultant) and Michael Bartlett (Professor, University of Georgia) discuss the analytical and regulatory challenges facing the field, exploring key gaps in impurity characterization and method development, the limitations of current chromatographic platforms in quality control settings, and the value of closer collaboration between academic and industry scientists.

Zitieren

APA

Neidigh, J., & Bartlett, M. (2026). Fireside chat: advancing analytical science and regulatory readiness for nucleic acid medicines. Nucleic Acid Insights, 3(5), 316–324. https://doi.org/10.18609/nuc.2026.037

Vancouver

Neidigh J, Bartlett M. Fireside chat: advancing analytical science and regulatory readiness for nucleic acid medicines. Nucleic Acid Insights. 2026;3(5):316–324. doi:10.18609/nuc.2026.037

BibTeX
@article{Neidigh2026,
  author = {Neidigh, Jonathan and Bartlett, Michael},
  title = {Fireside chat: advancing analytical science and regulatory readiness for nucleic acid medicines},
  journal = {Nucleic Acid Insights},
  year = {2026},
  volume = {3},
  number = {5},
  pages = {316–324},
  doi = {10.18609/nuc.2026.037}
}
Kostenlos starten →